Longevity Health Holdings, Inc. (XAGEW) — 10-Q Filings

10-Q Filings (6)

• Longevity Health Narrows Losses, Boosts Sales Post-Elevai Acquisition — Nov 14, 2025 Risk: high
  Longevity Health Holdings, Inc. (XAGEW) reported a net loss of $1,429,755 for the three months ended September 30, 2025, a significant improvement from the $2,8
• Longevity Health's Sales Soar Post-Acquisition, But Losses Widen — Aug 14, 2025 Risk: high
  Longevity Health Holdings, Inc. (XAGEW) reported a significant increase in net sales to $1,013,965 for the six months ended June 30, 2025, a substantial rise fr
• Longevity Health Holdings Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Longevity Health Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The company was formerly known as Carmell Corp and Carmell Therapeutics Cor
• Carmell Corp. Files Q3 2024 10-Q — Nov 14, 2024 Risk: medium
  Carmell Corp. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as ALPHA HEALTHCARE ACQUISITION CORP III, is in the surgical
• Carmell Corp Files 10-Q, Details Financials — Aug 14, 2024 Risk: medium
  Carmell Corp. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Carmell Therapeutics Corp and Alpha Healthcare Acquisition Corp
• Carmell Corp Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  Carmell Corp (XAGEW) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Carmell Corp filed a 10-Q report for the quarterly period ending March 31, 20

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX